Cargando…
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
Triple-Negative Breast Cancer (TNBC) has poor prognosis and no approved targeted therapy. We previously showed that the enzyme fatty acid synthase (FASN) was largely expressed in a small TNBC patients’ cohort and its inhibition synergized with cetuximab in TNBC preclinical mouse models. Here, we eva...
Autores principales: | Giró-Perafita, Ariadna, Sarrats, Ariadna, Pérez-Bueno, Ferran, Oliveras, Glòria, Buxó, Maria, Brunet, Joan, Viñas, Gemma, Miquel, Teresa Puig |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650350/ https://www.ncbi.nlm.nih.gov/pubmed/29088795 http://dx.doi.org/10.18632/oncotarget.20152 |
Ejemplares similares
-
Dual Fatty Acid Synthase and HER2 Signaling Blockade Shows Marked Antitumor Activity against Breast Cancer Models Resistant to Anti-HER2 Drugs
por: Blancafort, Adriana, et al.
Publicado: (2015) -
EGCG-Derivative G28 Shows High Efficacy Inhibiting the Mammosphere-Forming Capacity of Sensitive and Resistant TNBC Models
por: Giró-Perafita, Ariadna, et al.
Publicado: (2019) -
Breast Cancer Stem Cell Culture and Enrichment Using Poly(ε-Caprolactone) Scaffolds
por: Palomeras, Sònia, et al.
Publicado: (2016) -
Altered Glycosylation in Tumours Focused to Cancer Diagnosis
por: Peracaula, Rosa, et al.
Publicado: (2008) -
Whole-genome screen identifies diverse pathways that negatively regulate ciliogenesis
por: Failler, Marion, et al.
Publicado: (2021)